logo

For the Inventor, By the Inventor

Stevenage, United Kingdom

Caroline Whitworth

This inventor holds 8 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2003-2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Caroline Whitworth. Retrieved from https://idiyas.com/inventor/caroline-whitworth

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 12.2

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:

goldMedal4 out of 1,170 
 
Glaxo Group Limited
 patents
silverMedal4 out of 2,198 
 
Smithkline Beecham Corporation
 patents

Years Active: 2003-2009

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 7517879 - Pyrrolidine derivatives as factor Xa inhibitors (2009-04-14),
2. 7429587 - Pyrrolidine derivatives as factor Xa inhibitors (2008-09-30),
3. 7326785 - Pyrrolidine derivatives as factor XA inhibitors (2008-02-05),
4. 7282497 - Pyrrolidin-2-one derivatives as inhibitors of factor xa (2007-10-16),
5. 7226929 - Pyrrolidin-2-one derivatives as inhibitors of factor xa (2007-06-05),
6. 7186717 - Pyrrolidine derivatives as Factor Xa inhibitors (2007-03-06),
7. 7084139 - Pyrrolidin-2-one derivatives as inhibitors of factor Xa (2006-08-01),
8. 6534486 - 2-(purin-9-yl)-Tetrahydrofuran-3,4-diol derivatives (2003-03-18),

Title: The Innovative Mind of Caroline Whitworth

Introduction

Caroline Whitworth is a prominent inventor based in Stevenage, GB, known for her significant contributions to the field of pharmaceuticals. With a robust portfolio of 8 patents, Caroline has focused her research on developing new compounds that aim to improve medical treatments, particularly in the area of Factor Xa inhibition.

Latest Patents

Among her latest patents are innovative pyrrolidine derivatives, which are designed as Factor Xa inhibitors. These inventions involve compounds that possess unique chemical structures and processes for their preparation. The pharmaceutical compositions developed from these compounds are particularly valuable for ameliorating clinical conditions where Factor Xa inhibition is indicated.

Career Highlights

Throughout her career, Caroline has worked with reputable companies in the pharmaceutical sector, including SmithKline Beecham Corporation and Glaxo Group Limited. Her expertise and dedication to her work have established her as a noteworthy figure in the industry, contributing to advances in medicinal chemistry and therapeutics.

Collaborations

Caroline has collaborated with esteemed colleagues in her field, including Chuen Chan and Julie Nicole Hamblin. These collaborations have fostered a rich environment for innovation and scientific discovery, further advancing the development of new healthcare solutions.

Conclusion

With her extensive patent portfolio and active involvement in pharmaceutical research, Caroline Whitworth exemplifies the spirit of innovation in the medical field. Her work continues to impact the treatment landscape, paving the way for future advancements in drug development and therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…